news, journals and articles from all over the world.
A Penn State College of Medicine research team will continue to work on developing a vaccine for COVID-19 using more than $400,000 in funding from the Pennsylvania Department of Community and Economic Development.
Read moreGeorge Washington University researchers found five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients. Published in Future Medicine, these findings will help physicians better predict outcomes for COVID-19 patients in the U.S.
Read moreIn our series, The ECS Community Adapts and Advances, Netzahualcóyotl (Netz) Arroyo-Currás talks about his lab’s challenge as part of the pandemic response of Johns Hopkins Medicine, which is at the forefront of COVID-19 research. Soon after classes went online and labs were shuttered, his team shifted gears to quickly design a COVID-19 diagnostic device to help meet the urgent need to re-open work and study environments.
Read moreJoe Stetter is an optimist, inventor, entrepreneur, and owner of two small businesses that stayed open through the lockdown. KWJ Engineering and Spec Sensors manufacture essential health and safety sensors with medical and industrial applications. In our series, The ECS Community Adapts and Advances, Joe shares the challenges of doing business “not as usual”, and reports on a research collaboration he mobilized to improve PPE sterilization for COVID-19 frontline workers.
Read moreMemorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Read moreSweden’s controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.
Read moreRush University Medical Center has opened enrollment for a new clinical trial investigating whether the drug hydroxychloroquine is better than a placebo in preventing COVID-19 infection in healthy people working in health care settings.
Read moreMontefiore Health System and Albert Einstein College of Medicine have begun the next stage of the Adaptive COVID-19 Treatment Trial (ACTT), to evaluate treatment options for people hospitalized with severe COVID-19 infection. The new iteration of the trial, known as ACTT 2, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Read moreThe University of Texas Health Science Center at Houston (UTHealth) has teamed up with the White House Office of Science and Technology Policy and the National Institute of Standards and Technology (NIST) to develop search engines that will help streamline COVID-19 research for health care experts fighting the virus.
Read more
From a negative pressure helmet to enhanced protocols, investigators are adapting their research to focus on the COVID-19 pandemic.
Read moreMore than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital are participating in a pioneering study
Read more
Fred Hutchinson Cancer Research Center is launching a new COVID-19 research project called CovidWatch. This volunteer longitudinal study, aims to answer some of the most important questions about COVID-19